Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.26.1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Schedule of Stock Based Compensation Expense

Stock-based compensation expense is as follows (in thousands of dollars):

  

                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2026     2025     2026     2025  
Cost of revenues   $     $ 13     $ 13     $ 15  
Research and development           12       20       14  
Sales and marketing           329       60       394  
General and administrative     98       572       309       793  
Stock-based compensation expenses   $ 98     $ 926     $ 402     $ 1,216  
Schedule of Stock Option Activity

Stock option activity for the six months ended June 30, 2026, is set forth in the table below (price per share is in dollars):

 

    Options     Weighted
average
exercise
price per
share
    Weighted
average
remaining
contractual
life (in
years)
    Aggregate
Intrinsic
Value*
 
Outstanding at January 1, 2026     34,883     $ 110.67                  
Granted                            
Exercised                            
Forfeited and Expired     (32,162 )     110.52                  
Outstanding at June 30, 2026     2,721     $ 112.53       7.38     $  
Vested and Expected to Vest at June 30, 2026     2,721     $ 112.53       7.38     $  
Exercisable at June 30, 2026     2,374     $ 112.79       7.32     $  

 

* The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.
Schedule of Outstanding Restricted Stock Units

Restricted Stock Unit (“RSU”) activity for the six months ended June 30, 2026, is set forth in the table below:

 

    RSUs  
Outstanding at January 1, 2026      
Granted     85,000  
Released      
Forfeited      
Outstanding at June 30, 2026     85,000  
Warrant [Member]  
Schedule of Warrant Activity

Warrants activity, as adjusted for the Reverse Stock Split, for the three months ended June 30, 2026, is as follows:

 

    Number of warrants     Weighted
average
exercise
price per
share
 
Outstanding at January 1, 2026     62,979     $ 13.75  
Granted            
Forfeited            
Expired            
Outstanding at June 30, 2026     62,979     $ 13.75  
Exercisable at June 30, 2026     62,979     $ 13.75